Literature DB >> 1439789

Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism.

L G Goldfarb1, R B Petersen, M Tabaton, P Brown, A C LeBlanc, P Montagna, P Cortelli, J Julien, C Vital, W W Pendelbury.   

Abstract

Fatal familial insomnia (FFI) and a subtype of familial Creutzfeldt-Jakob disease (CJD), two clinically and pathologically distinct diseases, are linked to the same mutation at codon 178 (Asn178) of the prion protein gene. The possibility that a second genetic component modified the phenotypic expression of the Asn178 mutation was investigated. FFI and the familial CJD subtype segregated with different genotypes determined by the Asn178 mutation and the methionine-valine polymorphism at codon 129. The Met129, Asn178 allele segregated with FFI in all 15 affected members of five kindreds whereas the Val129, Asn178 allele segregated with the familial CJD subtype in all 15 affected members of six kindreds. Thus, two distinct disease phenotypes linked to a single pathogenic mutation can be determined by a common polymorphism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1439789     DOI: 10.1126/science.1439789

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  144 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

Review 2.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

3.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

4.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

5.  Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.

Authors:  T L McGee; M Devoto; J Ott; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

6.  Polymorphic changes in the KAL1 gene: not all of them should be classified as polymorphisms.

Authors:  D Söderlund; F Vilchis; J P Méndez
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

7.  Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD.

Authors:  Manuela Pastore; Steven S Chin; Karen L Bell; Zhiqian Dong; Qiwei Yang; Lizhu Yang; Jue Yuan; Shu G Chen; Pierluigi Gambetti; Wen-Quan Zou
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

8.  De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis.

Authors:  Christina J Sigurdson; K Peter R Nilsson; Simone Hornemann; Mathias Heikenwalder; Giuseppe Manco; Petra Schwarz; David Ott; Thomas Rülicke; Pawel P Liberski; Christian Julius; Jeppe Falsig; Lothar Stitz; Kurt Wüthrich; Adriano Aguzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

9.  The molecular genetics of human sleep.

Authors:  Luoying Zhang; Ying-Hui Fu
Journal:  Eur J Neurosci       Date:  2018-09-20       Impact factor: 3.386

Review 10.  The consequences of pathogenic mutations to the human prion protein.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Protein Eng Des Sel       Date:  2009-07-14       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.